Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
1.670
+0.070 (4.37%)
At close: Mar 9, 2026, 4:00 PM EDT
1.600
-0.070 (-4.19%)
After-hours: Mar 9, 2026, 6:07 PM EDT
Traws Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 13 | 32 | 16 | 14 | 53 | 86 | |
| Market Cap Growth | -22.06% | 106.05% | 15.90% | -74.63% | -38.16% | 123.22% | |
| Enterprise Value | 7 | 27 | -10 | -29 | -6 | 62 | |
| Last Close Price | 1.67 | 8.88 | 18.64 | 16.14 | 63.75 | 174.67 | |
| PS Ratio | 4.69 | 142.78 | 69.29 | 59.79 | 235.71 | 372.94 | |
| PB Ratio | 2.62 | -1.02 | 1.47 | 0.48 | 1.16 | 13.95 | |
| P/TBV Ratio | 6.76 | - | 1.47 | 0.48 | 1.16 | 13.95 | |
| EV/Sales Ratio | 2.43 | 118.84 | - | - | - | 268.19 | |
| Net Debt / Equity Ratio | -1.41 | 0.68 | -1.95 | -1.37 | -1.19 | -3.08 | |
| Net Debt / EBITDA Ratio | 0.41 | 0.86 | 1.03 | 1.98 | 3.34 | 0.76 | |
| Net Debt / FCF Ratio | 0.33 | 0.72 | 1.16 | 2.38 | 2.83 | 0.82 | |
| Asset Turnover | 0.27 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Quick Ratio | 1.07 | 2.00 | 2.26 | 4.82 | 9.01 | 1.90 | |
| Current Ratio | 1.22 | 2.16 | 2.46 | 4.89 | 9.07 | 1.97 | |
| Return on Equity (ROE) | -1059.63% | - | -97.22% | -50.96% | -61.81% | -283.48% | |
| Return on Assets (ROA) | -92.29% | -65.35% | -40.89% | -25.87% | -27.32% | -71.56% | |
| Return on Capital Employed (ROCE) | -346.50% | -185.50% | -150.80% | -62.70% | -33.40% | -250.80% | |
| Earnings Yield | -68.61% | -516.07% | -121.00% | -140.35% | -30.34% | -29.20% | |
| FCF Yield | -145.88% | -92.33% | -114.60% | -120.59% | -36.58% | -26.80% | |
| Buyback Yield / Dilution | -570.57% | -84.94% | -0.39% | -24.22% | -45.07% | -1109.88% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.